FDA to weigh easing limits on peptides promoted by RFK Jr. NBC 6 South Florida FDA Is Expected to Lift Restriction on Peptides, Heeding RFK Jr.'s Wishes The New York Times FDA to Convene Expert Panel on Expanding Access to Peptides Amid Safety, Regulatory Debate AJMC BPC 157 Dosing (Common Protocols), Oral Subcutaneous, 500 mcg daily, Duration: 6 weeks, Intramuscular Peritendinous, 1 mg daily, Duration: 6 weeks, Note:, Not approved by FDA or FDA Targets GLP 1 and Peptide Compounding, Advertising and 'Research Use Only' Labeling